Cytodyn Inc (CYDY)

[tonecee]

Seeking Alpha article that mentions CYDY

Gilead: M&A Coming Soon
Dec. 2, 2016 11:32 AM • GILD

"Even in HIV, where Gilead will likely be ceasing further R&D research beyond what is currently in the pipeline, there are targets such as CytoDyn's (OTCQB:CYDY) PRO-140 that offer different mechanisms by which to fight the virus and offer less hepatotoxicity concerns than existing HAART drugs. And on the long-acting (LA) treatments, John Milligan, CEO of Gilead, even mentioned during the Piper Jaffray conference that LA treatments in HIV patients may have better efficacy in a real world setting where patients are more likely to forget to take pills. This can add value to payers, as negligence becomes less of a concern (and which is nearly impossible to measure in clinical trials)."

Full Article:

Gilead: M&A Coming Soon $GILD http://www.seekingalpha.com/article/4027844